Evidence map›Paper›PMID 42817830›Full record

ArticleThe Journal of infectious diseases2026

The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.

Beatrice Z Sim, Julie M Steinbrink, Cameron Miller, Alejandro Antonia, J Andrew Alspaugh, Deng B Madut, Manuela Carugati, John A Crump, Blandina T Mmbaga, James S Ngocho and 6 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Beatrice Z SimSir Peter MacCallum Department of Oncology, University of Melbourne, Australia.ORCID 0000-0003-1845-4476
Julie M SteinbrinkDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0003-0771-3647
Cameron MillerDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Alejandro AntoniaDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0003-4387-6398
J Andrew AlspaughDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.
Deng B MadutDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0003-4023-3928
Manuela CarugatiDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-3187-5905
John A CrumpDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-4529-102X
Blandina T MmbagaDuke Global Health Institute, Duke University, Durham, NC  USA.ORCID 0000-0002-5550-1916
James S NgochoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Asia H KipengeleKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Philoteus A SakasakaKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Nathaniel H KalengoKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID 0000-0003-3838-0312
Matthew P RubachDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0001-5262-1421
Micah T McClainDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA.

Funding

Sepsis Characterization in KilimanjaroR01AI155733 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2020 to 2024
$3.4M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Novel Host-Response Biomarker Diagnostics for Invasive AspergillosisK23AI187748 · NIAID · DUKE UNIVERSITY · PI Julie Marie Steinbrink · 2025 to 2026
$363k
FIC NIH HHS R01 TW009237NIAID NIH HHS K23 AI187748NIAID NIH HHS R01 AI121378NIAID NIH HHS R01 AI155733
6 · The paper itself

Abstract

backgroundCryptococcus causes life-threatening infections; however, immune programs driving pathogenesis of these infections in the human host remain incompletely described. We leveraged whole-blood transcriptomic analysis to define distinct, conserved elements of the host immune response in participants with cryptococcal infections.

methodsRNA sequencing was performed on whole blood from adult febrile inpatients admitted to two hospitals in Moshi, Tanzania to compare gene expression between participants with cryptococcal, bacterial, or viral diseases, and adult community controls. Differential expression and gene set enrichment analyses were used to characterize expression differences between pathogen-class groups. Penalized logistic regression was used to identify gene expression signatures capable of identifying Cryptococcus disease.

resultsOut of 118 participants, 13 (11%) had cryptococcal disease and 41 (34.7%) were persons living with HIV (PLWH). Genes upregulated in response to cryptococcosis compared to non-acutely-infected community controls reflected complement activation, neutrophil activation, type I interferon signaling, and myeloid dendritic cell differentiation. When compared to combined bacterial or viral illnesses, cryptococcal disease demonstrated hyperactivation of both innate and humoral immune pathways. A series of classifiers were developed that distinguished between cryptococcal and combined bacterial or viral diseases with an AUC of 0.946.

conclusionOverall, the host response to cryptococcosis in individuals with advanced HIV as manifested in transcriptional profiles informs our understanding of the pathophysiology of and susceptibility to cryptococcal infection and may support development of novel diagnostic and therapeutic approaches.

Indexed as

Cryptococcushost responseRNA sequencingtranscriptomics

Identifiers

PMID42817830
PMCPMC13652361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.